Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

NCT02789189 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Recurrent and Metastatic Nasopharyngeal Carcinoma

Interventions

DRUG: nedaplatin and gemcitabine

Sponsor

Sun Yat-sen University